| 20th week of 2012 patent applcation highlights part 55 |
| Patent application number | Title | Published |
|---|
| 20120123100 | METHOD FOR PRODUCING TRANSFORMED EARTHWORMS USING EARTHWORM GONAD-REGENERATION CAPABILITY, TRANSFORMED EARTHWORMS THEREOF, AND METHOD FOR PRODUCING RECOMBINANT PROTEINS FROM TRANSFORMED EARTHWORM BODY FLUIDS - The present invention relates to a method for producing transformed earthworms using the gonad-regenerating capability of earthworms, to transformed earthworms produced by the method, and to a method for producing recombinant proteins from the body fluids of transformed earthworms. The method for producing transformed earthworms according to the present invention is a novel biotechnology technique which overcomes the drawbacks of conventional transgenesis techniques, and which has high injection efficiency. The method for producing transformed earthworms according to the present invention uses regenerative blast cells having totipotency, such as embryonic stem cells, and therefore, recombinant genes can be incorporated throughout the entire transformant, and recombinant proteins can be made from the body fluids of the transformant. The method of the present invention injects a target gene directly into a gonad, thus eliminating the need of a surrogate (animal), and uses a fertile transformant, thus continuously producing a plurality of transformants. The method of the present invention is simpler than conventional transgenesis techniques, and does not require expensive equipment or expertise. | 2012-05-17 |
| 20120123101 | Thiophene Azo Dyes and Laundry Care Compositions Containing the Same - This application relates to thiophene azo dyes for use as hueing agents, laundry care compositions comprising such thiophene azo dyes, processes for making such thiophene azo dyes, and laundry care compositions and methods of using the same. The thiophene azo dyes contain a formally charged moiety and are generally comprised of at least two components: at least one chromophore component and at least one polymeric component. Suitable chromophore components generally fluoresce blue, red, violet, or purple color when exposed to ultraviolet light, or they may absorb light to reflect these same shades. These thiophene azo dyes are advantageous in providing a hueing effect, for example, a whitening effect to fabrics, while not building up over time and causing undesirable blue discoloration to the treated fabrics. The thiophene azo dyes are also generally stable to bleaching agents used in laundry care compositions. | 2012-05-17 |
| 20120123102 | MODIFIED PECTINS, COMPOSITIONS AND METHODS RELATED THERETO - The present invention provides compositions of modified pectin and methods for preparing and using them. | 2012-05-17 |
| 20120123103 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS - Provided are compositions comprising one or more compounds having a structure comprising a node structure with from four to twelve carbon atoms, one or more (poly)glyceryl groups, and one or more hydrophobic moieties, wherein each of the one or more (poly)glyceryl groups is linked to the node structure by a first primary linking group, the one or more hydrophobic moieties are each independently linked either to the node structure by a primary linking group or to one of the (poly)glyceryl groups by a secondary linking group, and wherein the polyglyceryl thickener has an average degree of glyceryl polymerization of from greater than 3 to less than about 11 and an average number of hydrophobic groups per primary linking group of about 0.35 or greater. Also provided are polyglyceryl compounds, compositions comprising water, a surfactant, and a polyglyceryl thickener, as well as, methods of making polyglyceryl compounds and compositions of the present invention. | 2012-05-17 |
| 20120123104 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS - Provided are compositions comprising one or more compounds having a structure comprising a node structure with from four to twelve carbon atoms, one or more (poly)glyceryl groups, and one or more hydrophobic moieties, wherein each of the one or more (poly)glyceryl groups is linked to the node structure by a first primary linking group, the one or more hydrophobic moieties are each independently linked either to the node structure by a primary linking group or to one of the (poly)glyceryl groups by a secondary linking group, and wherein the polyglyceryl thickener has an average degree of glyceryl polymerization of from greater than 3 to less than about 11 and an average number of hydrophobic groups per primary linking group of about 0.35 or greater. Also provided are polyglyceryl compounds, compositions comprising water, a surfactant, and a polyglyceryl thickener, as well as, methods of making polyglyceryl compounds and compositions of the present invention. | 2012-05-17 |
| 20120123105 | Gene Signature for Diagnosis and Prognosis of Breast Cancer and Ovarian Cancer - A first embodiment is a breast cancer prognosticator comprising a detection mechanism consisting a 15-gene signature. In addition there are embodiments comprised of 23-gene signatures and 28-gene signatures. The 28-gene signature may also be used for the prognosis of ovarian cancer. Another embodiment is a method to determine relapse free potential in breast cancer patients comprising collecting a sample from an individual, removing marker-derived polynucleotide from said sample, using a detection mechanism to search for positive matches of said polynucleotides and a 24-gene signature, and developing a quantitative expression profile. | 2012-05-17 |
| 20120123106 | METHOD FOR ISOLATING HIGH-PURITY RNA BY MEANS OF PARAMAGNETIC MICROPARTICLES AND NANOPARTICLES - The invention relates to a purification method for high-purity, DNA-free RNA using a mixture of nanocarrier beads and paramagnetic beads. | 2012-05-17 |
| 20120123107 | NUCLEIC ACID CLEAVAGE COMPLEX AND METHOD FOR USING THE SAME - A nucleic acid cleavage complex is disclosed, which includes: a nanoparticle, a nucleic acid cleavage reagent, and a polynucleotide chain specifically recognizing a sequence of a target nucleic acid and having a first terminal and a second terminal opposite to the first terminal, wherein the first terminal is connected to the nanoparticle, the second terminal is connected to the nucleic acid cleavage reagent, and the first terminal sequence and the second terminal sequence are base-paired to make the polynucleotide chain form a hairpin. Also, a method for using the nucleic acid cleavage complex is also disclosed. | 2012-05-17 |
| 20120123108 | Bcl Gene Primers for Detection and Fingerprinting of Bacillus anthracis - detection primers can be used to amplify the conserved regions of bclB alleles encoding the collagen-like proteins found in | 2012-05-17 |
| 20120123109 | Luminescence quenching compounds - The quenching compounds of the invention are weakly luminescent cyanines that are substituted by one or more heteroaromatic quenching moieties. The quenching compounds of the invention exhibit little or no observable luminescence and efficiently quench a broad spectrum of luminescent compounds. The chemically reactive quenching compounds possess utility for labeling a wide variety of substances, including biomolecules. These labeled substances are highly useful for a variety of energy-transfer assays and applications. | 2012-05-17 |
| 20120123110 | Plasmid DNA Extraction Process - A process for the extraction of pDNA from cells is provided. In one aspect, the process comprises heating a liquid comprising the cells to an average temperature of from 95° C. to about 120° C. for a time of less than 10 seconds. In certain preferred aspects, the pDNA is extracted by the use of flow-through apparatus. | 2012-05-17 |
| 20120123111 | N -Hydroxy-L-Arginine Derivatives for the Treatment of Diseases - The present invention relates to physically-chemically and pharmacokinetically enhanced N | 2012-05-17 |
| 20120123112 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A HALOGENATED IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM - This invention relates to novel compositions comprising regioselectively substituted cellulose esters. One aspect of the invention relates to processes for preparing regioselectively substituted cellulose esters from cellulose dissolved in ionic liquids. Another aspect of the invention relates to the utility of regioselectively substituted cellulose esters in applications such as protective and compensation films for liquid crystalline displays. | 2012-05-17 |
| 20120123113 | DI-SUBSTITUTED PYRIDINUM POLYMERS AND SYNTHESIS THEREOF - A method of producing a di-substituted pyridinium polymer by microwave-assisted polymerisation of a 2, 3, or 4-substituted pyridine monomer of the formula NC | 2012-05-17 |
| 20120123114 | QUINAZOLINE DERIVATIVES HAVING TYROSINE KINASE INHIBITORY ACTIVITY - A compound which inhibits both of EGF receptor tyrosine kinase and HER2 tyrosine kinase is provided. | 2012-05-17 |
| 20120123115 | CYCLIC GUANIDINE IONIC LIQUID - Disclosed is an ionic liquid which is stable over a wide potential range and exhibits a high ionic conductivity. The ionic liquid comprises a cyclic guanidine salt represented by the following formula (1): | 2012-05-17 |
| 20120123116 | APPLICATION OF 2, 3 - DIHYDRO-3 - HYDROXYMETHYL -6 - AMINO - [1,4 ] - BENZOXAZINE IN PREPARATION OF DRUGS INDUCING EMBRYONIC STEM CELLS TO DIFFERENTIATE TO VASCULAR ENDOTHELIAL CELLS - An application of 2,3-dihydro-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in the preparation of drugs inducing embryonic stem cells to differentiate to vascular endothelial cells, wherein the concentration of the 2,3-dihydro-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in the preparation of drugs effectively inducing mouse embryonic stem cells to differentiate to vascular endothelial cells is 1˜20 μM. The 2,3-dihydro-3-hydroxymethyl-6-amino-[1,4]-benzoxazine provided by the invention lays foundation for preparing and developing drugs inducing embryonic stem cells to differentiate to vascular endothelial cells, can be used as an effective research tool of embryonic stem cells, and can be used for researching on embryonic stem cell differentiation and new molecular mechanisms of blood vessel formation. | 2012-05-17 |
| 20120123117 | Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex - An organometallic complex is provided by which favorable red-color light emission can be obtained. Further, an organometallic complex having a peak of light emission at about 620 nm is provided because the wavelength of light which is perceived as excellent red-color light is about 620 nm. Furthermore, an organometallic complex is provided by which red-color light emission with high luminous efficiency (cd/A) can be obtained. An organometallic complex represented by the following general formula (G2) and a light-emitting element, a light-emitting device, and an electronic device including the organometallic complex represented by the following general formula (G2) are provided. | 2012-05-17 |
| 20120123118 | Process For The Preparation Of Nitroorotic Acid - Subject of the present invention is a new improved process for the preparation of nitroorotic acid via nitration of orotic acid. | 2012-05-17 |
| 20120123119 | ACYCLIC NUCLEOSIDE DERIVATIVES - Methods and novel intermediates for the preparation of and the treatment with acyclic nucleoside derivatives of the formula: | 2012-05-17 |
| 20120123120 | No-Carrier-Added Nucleophilic [F-18] Fluorination of Aromatic Compounds - Phenyliodonium ylide derivatives substituted with electron donating as well as electron withdrawing groups on the aromatic ring are shown for use as precursors in aromatic nucleophilic substitution reactions. The iodonium ylide group is substituted by nucleophiles such as halide ions to provide the corresponding haloaryl derivatives. No-carrier-added [F-18]fluoride ion exclusively substitutes the iodonium ylide moiety in these derivatives and provides high specific activity F-18 labeled fluoro derivatives. Protected L-dopa-6-iodonium ylide derivative have been synthesized as a precursors for the preparation of no-carrier-added 6-[F-18]fluoro-L-dopa. The iodonium ylide group in this L-dopa.derivative is nucleophilically substituted by no-carrier-added [F-18]fluoride ion to provide a [F-18]fluoro intermediates which upon acid hydrolysis yielded 6-[F-18]fluoro-L-dopa. | 2012-05-17 |
| 20120123121 | SYNTHESIS OF PICOPLATIN - An improved method for the synthesis of the anticancer drug picoplatin is provided. Condensation of a tetrachloroplatinate salt (TCP), such as potassium tetrachloroplatinate, and 2-picoline, in a solvent, is catalyzed by the presence of oxygen, such as in air, and additionally catalyzed by the presence of a Pt | 2012-05-17 |
| 20120123122 | METHOD FOR MANUFACTURING A BORONIC ACID ESTER COMPOUND - The present invention relates to a method for manufacturing a boronic acid ester compound, characterized by reacting an aryl halide compound and a diboron ester compound in the presence of a nitrogen-containing organic base, a nickel catalyst, a phosphine compound and a solvent. According to the manufacturing method of the present invention, even if a nickel catalyst is used as the catalyst, a desired boronic acid ester compound can be obtained in a sufficiently high yield. Furthermore, even if aryl chloride or aryl bromide having relatively low price and low reactivity, was used as the aryl halide compound, a desired boronic acid ester compound can be obtained in a sufficiently high yield. | 2012-05-17 |
| 20120123123 | PREPARATION OF NALMEFENE HYDROCHLORIDE FROM NALTREXONE - Method for producing nalmefene hydrochloride from naltrexone, which method is particular well adapted for large-scale industrial application, and has been found to be efficient, to give a high yield and to afford highly pure nalmefene hydrochloride salt. | 2012-05-17 |
| 20120123124 | Manufacturing process for Tadalafil from racemic or L-tryptophan - The present invention relates to a novel manufacturing process of pharmaceutically active compound of formula I, having (6R,12aR)-configuration, used for treatment of erectile dysfunction. Starting from racemic or L-tryptophan the invention describes preparation of an enantiomerically pure intermediate of formula II which is a known precursor in the synthesis of Tadalafil (formula I). | 2012-05-17 |
| 20120123125 | Manufacturing process for tiotropium bromide - The present invention relates to a novel manufacturing process of pharmaceutically active compound of formula I used as a long-acting anticholinergic bronchodilator. Starting from oxalic acid derivative of formula III the invention describes preparation of a novel cyclic anhydride of formula II which is very efficient precursor in the synthesis of Tiotropium bromide (compound of formula I). | 2012-05-17 |
| 20120123126 | Compounds As c-Met Kinase Inhibitors - The present invention relates to compounds, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states associated with the inhibition of the protein tyrosine kinase activity of growth factor receptors such as c-Met, thereby making them useful as anticancer agents, to their use as medicaments for use in the production of inhibition of tyrosine kinases reducing effects in warm-blooded animals such as humans. | 2012-05-17 |
| 20120123127 | PROCESS FOR PRODUCING THIABENZOAZULENE-PROPIONIC ACID DERIVATIVE - Disclosed is a process for producing a thiabenzoazulene-propionic acid derivative which is useful as an active ingredient of an antihistaminic agent or the like. According to the producing process of the present invention, it is possible to produce a thiabenzoazulene-propionic acid derivative where the 2-position of the thiabenzoazulene skeleton is substituted with propionic acid. The thiabenzoazulene propionic-acid derivative thus synthesized has excellent antagonistic action to histamine H1 receptor and low intracerebral transmigration and, therefore, is useful as an active ingredient of the pharmaceutical composition such as an antihistaminic agent. | 2012-05-17 |
| 20120123128 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE NIPECOTAMIDE - Optically active nipecotamide can be produced by a method for producing optically active nipecotamide comprising: a step of reacting nipecotamide with optically active lactic acid to prepare a mixture of diastereomer salts and then allowing one diastereomer salt in the mixture of the diastereomer salts to precipitate; a step of collecting the precipitated diastereomer salt; and, a step of treating the collected diastereomer salt with a base to cause optically active nipecotamide to release. | 2012-05-17 |
| 20120123129 | Cyclopentanedione Compounds and Their Use as Insecticides, Acaricides and/or Fungicides - The present invention relates to the use of compounds of Formula (I) | 2012-05-17 |
| 20120123130 | PROCESS FOR THE PREPARATION OF 2,2-DIFLUOROETHYLAMINE DERIVATIVES STARTING FROM N-(2,2-DIFLUOROETHYL)PROP-2-EN-1-AMINE - Process for the preparation of 2,2-difluoroethylamine derivatives of the formula (IV) | 2012-05-17 |
| 20120123131 | PROCESS FOR THE PREPARATION OF STRONTIUM RANELATE - The present invention relates to an improved process for the synthesis of strontium ranelate or hydrates thereof. More particularly, the present invention relates to an effective process for the preparation of a compound of formula III, which is a useful intermediate in the synthesis of strontium ranelate. | 2012-05-17 |
| 20120123132 | NOVEL CRYSTALLINE FORM OF ATORVASTATIN HEMI-CALCIUM SALT, HYDRATE THEREOF, AND METHOD OF PRODUCING THE SAME - The present invention provides a novel crystalline form of [R-(R | 2012-05-17 |
| 20120123133 | ORGANOMETALLIC RUTHENIUM COMPLEXES AND RELATED METHODS FOR THE PREPARATION OF TETRA-SUBSTITUTED AND OTHER HINDERED OLEFINS - The invention relates to ruthenium alkylidene complexes having an N-heterocyclic carbene ligand comprising a 5-membered heterocyclic ring having a carbenic carbon atom and at least one nitrogen atom contained within the 5-membered heterocyclic ring, wherein the nitrogen atom is directly attached to the carbenic carbon atom and is substituted by a phenyl ring, and wherein the phenyl ring has a hydrogen at either or both ortho positions and is substituted at at least one ortho or meta position. The invention also relates to an olefin metathesis reactions and particularly to the preparation of tetra-substituted cyclic olefins via a ring-closing metathesis. | 2012-05-17 |
| 20120123134 | Manufacturing process for (S)-Pregabalin - The present invention relates to a novel manufacturing process and novel intermediates useful in the synthesis of pharmaceutically active compounds of general formula I used for treatment of epilepsy, neuropathic pain, anxiety and social phobia. The invention describes preparation of enantiomerically pure (S)-Pregabalin from chiral pyrrolidin-2-one of formula IV. | 2012-05-17 |
| 20120123135 | Method And Materials For Reverse Patterning - A silsesquioxane resin is applied on top of the patterned photo-resist and cured to produce a cured silsesquioxane resin on top of the pattern surface. Subsequently, an aqueous base stripper or a reactive ion etch recipe containing CF | 2012-05-17 |
| 20120123136 | PROCESS FOR THE PREPARATION OF 2-OXO-[1,3] DIOXOLANE-4-CARBOXYLIC ACID ESTERS - A process for the preparation of 2-oxo-[1,3] dioxolane-4-carboxylic acid esters of formula I | 2012-05-17 |
| 20120123137 | PROCESS FOR BETA-LACTONE PRODUCTION - The present application provides a method for producing an beta-lactone product. The method includes the steps of: reacting an epoxide, a solvent with a carbonylation catalyst and carbon monoxide to produce a reaction stream comprising a beta-lactone then separating a portion of the beta-lactone in the reaction stream from the solvent and carbonylation catalyst to produce: i) a beta-lactone stream with the beta-lactone, and ii) a catalyst recycling stream including the carbonylation catalyst and the high boiling solvent; and adding the catalyst recycling stream to the feed stream. | 2012-05-17 |
| 20120123138 | Catalyst support and process for the preparation thereof - An amorphous catalyst support comprising at least a first oxide selected from the group consisting of: silica, germanium oxide, titanium oxide, zirconium oxide or mixtures thereof, preferably silica gel beads or diatomaceous earth; a group 3 metal oxide; and anions in an amount not greater than 10% by weight of the catalyst support; wherein the group 3 metal oxide is incorporated in the first oxide structure at the molecular level. The catalyst support is prepared by (a) mixing the first oxide, with an anhydrous source of the group 3 metal oxide, and water, at a pH above 11, thus forming a suspension, (b) washing the catalyst support with water, (c) separating the catalyst support from the water, and (d) optionally drying and/or calcining the catalyst support. A catalyst based on such a support has improved catalytic properties. | 2012-05-17 |
| 20120123139 | BIODIESEL PURIFICATION BY A CONTINUOUS REGENERABLE ADSORBENT PROCESS - A process for the continuous purification of biodiesel (fatty acid alkyl esters (FAAE)) is described using a powdered, granulated or extruded adsorbent. The adsorbent is contained in a column system and is regenerated for reuse multiple times. The crude biodiesel is contacted with an adsorbent packed into a column, or multiple columns in series, for a sufficient amount of time to remove impurities such as, but not limited to, soaps, metals, free glycerin, sterol glucosides and many of the other impurities that reduce the stability of biodiesel. The resulting finished biodiesel exiting the column(s) is ready for the methanol recovery process. Once the adsorbent no longer removes the desired amount of impurities, it is regenerated for reuse. The solvent used for the regeneration process is reclaimed and reused by recycling it back to the transesterification reaction. | 2012-05-17 |
| 20120123140 | Production of Biodiesel and Glycerin from High Free Fatty Acid Feedstocks - A system and method for the conversion of free fatty acids to glycerides and the subsequent conversion of glycerides to glycerin and biodiesel includes the transesterification of a glyceride stream with an alcohol. The fatty acid alkyl esters are separated from the glycerin to produce a first liquid phase containing a fatty acid alkyl ester rich (concentrated) stream and a second liquid phase containing a glycerin rich (concentrated) stream. The fatty acid alkyl ester rich stream is then subjected to distillation, preferably reactive distillation, wherein the stream undergoes both physical separation and chemical reaction. The fatty acid alkyl ester rich stream is then purified to produce a purified biodiesel product and a glyceride rich residue stream. Neutralization of the alkaline stream, formed during the alkali-catalyzed transesterfication process, may proceed by the addition of a mineral or an organic acid. | 2012-05-17 |
| 20120123141 | OBTAINING FATTY ACIDS FROM INSECT LARVAE - Extract of oil rich in saturated, monounsaturated and polyunsaturated fatty acids containing oil extracted from insect larvae comprising saturated, MUFA and PUFA fatty acids and procedure for obtaining oil extract. | 2012-05-17 |
| 20120123142 | PROCESS FOR HYDROGENATING KETONES IN THE PRESENCE OF RU(II) CATALYSTS - The present invention relates to a process for hydrogenating a substrate comprising a carbon-heteroatom double bond, the process comprising the step of reacting the substrate with hydrogen gas in the presence of a hydrogenation catalyst, wherein the hydrogenation catalyst is a complex of formula (I): R | 2012-05-17 |
| 20120123143 | METHOD FOR PRODUCING ALKOXY-SUBSTITUTED 1,2-BISSILYLETHANES - The invention relates to a method for producing alkoxy-substituted 1,2-bissilylethanes of the general formula 1 | 2012-05-17 |
| 20120123144 | Manufacturing process for sitagliptin from L-aspartic acid - The present invention relates to a novel manufacturing process of pharmaceutically active compound of formula I used as oral anti-diabetic drug. Starting from L-aspartic acid derivate of formula IV the invention describes preparation of the chiral (R)-β-amino acid of formula II known as a precursor in the synthesis of Sitagliptin (formula I). | 2012-05-17 |
| 20120123145 | Novel Macromolecular Antioxidants Comprising Differing Antioxidant Moieties: Structures, Methods of Making and Using The Same - Described are antioxidant macromolecules and methods of making and using same. | 2012-05-17 |
| 20120123146 | METHOD FOR PRODUCING ESTER COMPOUND - Disclosed is an effective method for producing an ester compound at a reaction temperature lower than that of conventional methods, and with a high yield, even when inexpensive formic acid ester is used as a starting material. A method for producing an ester compound, the method comprising the step of reacting an organic compound having at least one unsaturated carbon bond in the molecule, and a formic acid ester in the presence of a catalyst system containing: a ruthenium compound; a cobalt compound; and a halide salt. | 2012-05-17 |
| 20120123147 | KETOCARBOXYLIC ACIDS, METHODS OF MANUFACTURE AND USES THEREOF - Ketocarboxylic acids such as levulinic acid can be efficiently purified in high yield by esterification with a hydrocarbon polyol to the corresponding polyketocarboxylic ester, which can be readily purified, for example recrystallized. After purification, the ketocarboxylic ester can be hydrolyzed to provide pure ketocarboxylic acid, or a salt thereof, after removal of the esterifying hydrocarbon polyol, or used for other synthetic transformations. Advantageously, the polyketocarboxylic esters, ketocarboxylic acids, and salts thereof produced by this method are obtained in high purity. | 2012-05-17 |
| 20120123148 | COMPOSITION INCLUDING DIALKYL TIN OXIDE AND USE THEREOF AS A TRANSESTERIFICATION CATALYST FOR THE SYNTHESIS OF (METH) ACRYLIC ESTERS - The present invention relates to a composition including a dialkyl tin oxide, such as DBTO, which can be used as a transesterification catalyst for the synthesis of (meth)acrylic esters. The invention also relates to a method for the synthesis of (meth)acrylic esters by transesterification in the presence of said composition. | 2012-05-17 |
| 20120123149 | Composition having hase rheology modifiers - A monomer compound that contains at least one polymerizable functional group per molecule, and at least one bicycloheptyl-, bicycloheptenyl-, or branched (C | 2012-05-17 |
| 20120123150 | Copper-Zirconia Catalyst and Method of Use and Manufacture - Catalysts and methods for their manufacture and use for the dehydrogenation of alcohols are disclosed. The catalysts and methods utilize a highly dispersible alumina, for example, boehmite or pseudoboehmite, to form catalysts that exhibit high dehydrogenation activities. Specifically, the catalysts include Cu that is highly dispersed by reaction of an alumina formed by peptizing of boehmite or pseudoboehmite and precursors of ZrO | 2012-05-17 |
| 20120123151 | PROCESS FOR PREPARING METHYLENEDI(PHENYL ISOCYANATE) - The invention relates to a process for preparing methylenedi(phenyl isocyanate), which comprises (a) the phosgenation of two-ring and/or multiring methylenedi(phenylamine), (b) the fractionation of the crude methylenedi(phenyl isocyanate) obtained to give two-ring and multiring isomers, (c) the purification and/or fractionation of the resulting mixture of two-ring isomers of methylenedi(phenyl isocyanate) and (d) the storage of the mixtures obtained in step (c) or in step (b), wherein part of the stored mixtures is reused by means of recirculation in at least one of steps (b) or (c). | 2012-05-17 |
| 20120123152 | PROCESS FOR THE PREPARATION OF ISOCYANATES - An isocyanate is produced by reacting an amine with a stoichiometric excess of phosgene in the gas phase. This reaction is carried out at a temperature above the amine's boiling point to obtain a liquid stream containing the isocyanate and a gas stream containing hydrogen chloride and phosgene. The gas stream containing hydrogen chloride and phosgene thus produced is separated into a gas stream containing hydrogen chloride and a liquid stream containing phosgene. At least part of the liquid stream containing phosgene is then converted to a gas stream containing phosgene which gas stream is then recycled. The gaseous phosgene stream is maintained at a higher pressure than the liquid phosgene stream. | 2012-05-17 |
| 20120123153 | METHOD FOR PURIFYING MIXTURES COMPRISING 4,4'-METHYLENEDIPHENYL DIISOCYANATE - The invention relates to a method for purifying mixtures comprising 4,4′-methylenediphenyl diisocyanate, which comprises purifying by distillation a mixture I comprising 4,4′-methylene-diphenyl diisocyanate by means of a column K1, wherein the gaseous stream comprising the mixture I is brought into contact in the column K1 with at least one liquid compound A which has the same or higher boiling point than 4,4′-methylenediphenyl diisocyanate, and wherein the gaseous stream O obtained at the top of the column and comprising 4,4′-methylenediphenyl diisocyanate is cooled in a maximum of 5 seconds to a temperature of 20° C. to 60° C. | 2012-05-17 |
| 20120123154 | METHOD FOR PRODUCING BIARYL COMPOUND - A method for producing a biaryl compound represented by the formula (2) | 2012-05-17 |
| 20120123155 | BIOCATALYST FOR CATALYTIC HYDROAMINATION - The present invention relates to a method for the enzymatic hydroamination of C—C double bonds catalyzed by enzymes structurally and/or functionally related to phenylalanine ammonia lyase (PAL) isolated from microorganisms of | 2012-05-17 |
| 20120123156 | COPRODUCTION OF ACETIC ACID AND ACETIC ANHYDRIDE - Disclosed is a process for the coproduction of acetic acid and acetic anhydride by producing in a first carbonylation reactor a carbonylation product mixture containing acetic anhydride, removing the carbonylation mixture from the first carbonylation reactor, contacting the carbonylation mixture with methanol to react with and convert some or all of the acetic anhydride contained in the mixture to acetic acid and methyl acetate, feeding the resulting reaction composition to a second carbonylation reactor and contacting the reaction composition to carbonylation. | 2012-05-17 |
| 20120123157 | FORMIC ACID MANUFACTURING SYSTEM AND METHOD OF MANUFACTURING FORMIC ACID - Formic acid manufacturing system and method of manufacturing formic acid. The formic acid manufacturing system includes a reactor, a first separation device, a second separation device, a reactive distillation device and a third separation device. Methyl formate is produced in the reactor by processing a conbonylation reaction of external carbon monoxide and methanol. Water is added into the reactive distillation device externally, and formic acid and methanol is produced in the reactive distillation device by hydrolyzing methyl formate with water. A formic acid solution is obtained from an output of the third separation device. | 2012-05-17 |
| 20120123158 | Method for Increasing Methionine Productivity Using a Mixture of Methyl Mercaptan and Dimethyl Sulfide - The present invention relates to a method for increasing L-methionine productivity and organic acid productivity. More particularly, the present invention relates to a method which involves adding a mixture containing methyl mercaptan and dimethyl sulfide at a appropriate ratio to O-acetyl homoserine or O-succinyl homoserine and to an enzyme having an activity of converting methionine precursor into L-methionine, so as to perform an enzyme reaction, to thereby improve the conversion rate of L-methionine and organic acid from the L-methionine precursor, and thus increasing L-methionine yield as compared to conventional method. | 2012-05-17 |
| 20120123159 | METHOD FOR PREPARING DIFLUOROACETIC ACID - A method for preparing difluoroacetic acid is described. The method can include: reacting a difluoroacetic acid ester with an aliphatic carboxylic acid which, after transesterification, results in the formation of difluoroacetic acid and the corresponding carboxylic acid ester, the carboxylic acid being selected such that the ester of the carboxylic acid has a lower boiling point than that of difluoroacetic acid; and removing the ester of the carboxylic acid by distillation as the ester forms, thus enabling the difluoroacetic acid to be recovered. | 2012-05-17 |
| 20120123160 | PROCESSES FOR PURIFICATION OF ACID SOLUTIONS - The invention provides processes for purification of streams containing carboxylic acids and carboxylic acid anhydrides without using the amount of high-cost, corrosion resistant alloy required for a distillation column. The invention provides methods in which streams containing carboxylic acids and carboxylic acid anhydrides are subjected to a hydrolysis process by combining them with a stoichiometric excess of water and optionally an added hydrolysis catalyst. The resulting hydrolyzed stream is subsequently separated to produce a stream containing carboxylic acid and water and a carboxylic acid product stream comprising carboxylic acid. | 2012-05-17 |
| 20120123161 | Process for Enantioselective Synthesis of Single Enantiomers of Modafinil by Asymmetric Oxidation - The invention relates to a method for preparing a sulphoxide compound of formula (I) either as a single enantiomer or in an enantiomerically enriched form, comprising the steps of:
| 2012-05-17 |
| 20120123162 | TRANSDERMAL COMPOSITION COMPRISING TOLTERODINE - A transdermal composition comprising tolterodine having improved storage stability is disclosed. The transdermal composition comprising tolterodine contains an antioxidant to stabilize tolterodine and can be stored for a long period of time. | 2012-05-17 |
| 20120123163 | PROCESS FOR THE PREPARATION OF 2,2-DIFLUOROETHYLAMINE STARTING FROM A BENZYLAMINE COMPOUND - Process for the preparation of 2,2-difluoroethylamine of the formula (I) | 2012-05-17 |
| 20120123164 | Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders - One aspect of the present invention relates to pharmaceutical compositions containing two or more active agents that when taken together can be used to treat, e.g., menopause, mood disorders, anxiety disorders, or cognitive disorders. The first component of the pharmaceutical composition is a sedative eszopiclone. The second component of the pharmaceutical composition is trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine. The present invention also relates to a method of treating menopause, perimenopause, mood disorders, anxiety disorders, and cognitive disorders. | 2012-05-17 |
| 20120123165 | CYCLOALIPHATIC DIAMINES AND METHOD OF MAKING THE SAME - The instant invention provides cycloaliphatic diamines and a method of making the same. The cycloaliphatic diamines according to the instant invention comprise the reaction product of one or more cycloaliphatic cyanoaldehydes selected from the group consisting of 1,3-cyanocyclohexane carboxaldehyde, 1,4-cyanocyclohexane carboxaldehyde, mixtures thereof, and combinations thereof, hydrogen, and ammonia fed into a continuous reductive amination reactor system; wherein the one or more cycloaliphatic cyanoaldehydes, hydrogen, and ammonia are contacted with each other in the presence of one or more heterogeneous metal based catalyst systems at a temperature in the range of from 80° C. to about 160° C. and a pressure in the range of from 700 to 3500 psig; and wherein one or more cycloaliphatic diamines are formed; and wherein said one or more cycloaliphatic diamines are selected from the group consisting of 1,3-bis(aminomethyl)cyclohexane, 1,4-bis(aminomethyl)cyclohexane, combinations thereof, and mixtures thereof. | 2012-05-17 |
| 20120123166 | METHOD OF PREPARING 1-HYDROXY-1,3,3,5,5-PENTAMETHYLCYCLOHEXANE - Method of preparing 1-hydroxy-1,3,3,5,5-pentamethylcyclohexane comprising step (ii): (ii) converting 3,3,5,5-tetramethylcyclohexanone to 1-hydroxy-1,3,3,5,5-pentamethylcyclohexane by using methylmagnesium chloride. 1-hydroxy-1,3,3,5,5-pentamethylcyclohexane may be used for preparing 1-amino-1,3,3,5,5-pentamethylcyclohexane (Neramexane) or a pharmaceutically acceptable salt thereof. | 2012-05-17 |
| 20120123167 | REACTION APPARATUS - A reaction apparatus which is used for conducting a gas-liquid chemical reaction in a state that a liquid is in a continuous phase, wherein its reactor has therein a shear type stirring impeller for dispersing a raw reaction gas or a carrier gas and a film-formed catalyst, which apparatus is capable of producing a target reaction product; and a process for producing a tertiary amine in such reaction apparatus. | 2012-05-17 |
| 20120123168 | PRODUCTION OF FUEL FROM CHEMICALS DERIVED FROM BIOMASS - Hydrocarbons may be formed from six carbon sugars. This process involves obtaining a quantity of a hexose sugar. The hexose sugar may be derived from biomass. The hexose sugar is reacted to form an alkali metal levulinate, an alkali metal valerate, an alkali metal 5-hydroxy pentanoate, or an alkali metal 5-alkoxy pentanoate. An anolyte is then prepared for use in a electrolytic cell. The anolyte contains the alkali metal levulinate, the alkali metal valerate, the alkali metal 5-hydroxy pentanoate, or the alkali metal 5-alkoxy pentanoate. The anolyte is then decarboxylated. This decarboxylating operates to decarboxylate the alkali metal levulinate, the alkali metal valerate, the alkali metal 5-hydroxy pentanoate, or the alkali metal 5-alkoxy pentanoate to form radicals, wherein the radicals react to form a hydrocarbon fuel compound. | 2012-05-17 |
| 20120123169 | PROCESS FOR PREPARING ALPHA,BETA-UNSATURATED C10-ALDEHYDES - The invention relates to a method for continuously producing α,β-unsaturated C | 2012-05-17 |
| 20120123170 | METHOD FOR PRODUCING NONIONIC SURFACTANT - The present invention relates to the method for producing a nonionic surfactant, including the step (I) of reacting alcohol having a water content of not more than 0.1% by mass with ethylene oxide to obtain ethylene oxide-adduct, the step (II) of reacting the ethylene oxide-adduct with propylene oxide to obtain the alkylene oxide-adduct having a content of remaining propylene oxide of not more than 1000 mg/kg, and the step (III) of reacting the alkylene oxide-adduct with ethylene oxide to obtain the nonionic surfactant having each content of remaining ethylene oxide and remaining propylene oxide of not more than 5 mg/kg. | 2012-05-17 |
| 20120123171 | Catalytic reduction of lignin acids and substituted aliphatic carboxylic acid compounds - Renewable resources comprising bagasse, corn stover, wood sawdust and switch grass are subject to direct catalytic conversion or bio-fermentation processes producing ethanol and organic by products leaving complex lignin compounds as waste for disposal. Chemical conversion of lignin compounds to aromatic lignin acids followed by reductive hydrogenation to cresol and substituted creosol compounds prepares these natural resources for chemical conversion to a form of gasoline and valued industrial compounds. The process disclosed herein is also applicable to organic carboxylic acid compounds such as natural oils producing valued liquid hydrocarbon fuels. | 2012-05-17 |
| 20120123172 | Production Method Of Trans-1,3,3,3-Tetrafluoropropene - Production of trans-1,3,3,3-tetrafluoropropene by reacting 1-chloro-3,3,3-trifluoropropene with hydrogen fluoride to obtain a reaction product A containing formed trans-1,3,3,3-tetrafluoropropene, unreacted 1-chloro-3,3,3-trifloropropene and hydrogen fluoride, and by-product cis-1,3,3,3-tetrafluoropropene, 1,1,1,3,3-pentafluoropropane and hydrogen chloride; distilling reaction product A to recover a distillation bottom product containing 1-chloro-3,3,3-trifloropropene and hydrogen fluoride and supplying recovered distillation bottom product to the reacting step; recovering hydrogen fluoride from a residue B remaining after recovery of the distillation bottom product and supplying recovered hydrogen fluoride to the reacting step; contacting a residue C remaining after recovery of hydrogen fluoride with water or aqueous sodium hydroxide solution to separate hydrogen chloride; dehydrating a residue D remaining after separation of hydrogen chloride; and distilling a residue E remaining after the dehydration to obtain trans-1,3,3,3-tetrafluoropropene. The method reuses unreacted reactants and produces the target compound efficiently. | 2012-05-17 |
| 20120123173 | Process For Production Of 2-Chloro-3,3,3-Trifluoropropene - There is provided according the present invention a process for producing 2-chloro-3,3,3-trifluoropropene, comprising: hydrogenating 1,2-dichloro-3,3,3-trifluoropropene with hydrogen (H | 2012-05-17 |
| 20120123174 | CATALYST FOR SELECTIVE HYDROGENATION OF ACETYLENE COMPOUNDS - The present invention provides a catalyst for selective hydrogenation used to obtain 1,3-butadiene by selectively hydrogenating acetylene compounds contained in a C4 hydrocarbon compound reservoir which is obtained by steam cracking and mainly contains 1,3-butadiene. This catalyst composition mainly contains palladium and bismuth, or palladium, bismuth and tellurium. | 2012-05-17 |
| 20120123175 | PROCESSES FOR INCREASING THE YIELD OF ETHYLENE AND PROPYLENE - A process for increasing the yield of ethylene and propylene, comprising: | 2012-05-17 |
| 20120123176 | METHANE AROMATIZATION CATALYST, METHOD OF MAKING AND METHOD OF USING THE CATALYST - A catalyst for converting methane to aromatic hydrocarbons is described herein. The catalyst comprises an active metal or a compound thereof, and an inorganic oxide support wherein the active metal is added to the support in the form of metal oxalate. The metal oxalate-derived catalyst exhibits superior performance in the conversion of methane-rich feed to aromatics products relative to catalysts prepared from non-oxalate metal precursors. A method of making the catalyst and a method of using the catalyst are also described. | 2012-05-17 |
| 20120123177 | PROCESS FOR THE PREPARATION OF HYDROGENATED HYDROCARBON COMPOUNDS - A process for the dehydrogenation of a paraffinic hydrocarbon compound, such as an alkane or alkylaromatic hydrocarbon compound to produce an unsaturated hydrocarbon compound, such as an olefin or vinyl aromatic compound or mixture thereof, in which a dehydrogenation catalyst contacts gaseous reactant hydrocarbons in a reactor at dehydrogenation conditions. | 2012-05-17 |
| 20120123178 | UZM-35HS ALUMINOSILICATE ZEOLITE, METHOD OF PREPARATION AND PROCESSES USING UZM-35HS - A new family of crystalline aluminosilicate zeolites has been synthesized. These zeolites are represented by the empirical formula. | 2012-05-17 |
| 20120123179 | PROCESSES FOR PRODUCING LIGHT OLEFINS - A process for producing light olefins. A feedstock enters a pre-reaction zone and contacts a catalyst comprising at least one silicon-aluminophosphate molecular sieve and produces a gas-phase stream and a catalyst to be regenerated; the gas-phase stream and catalyst to be regenerated enter at least one riser, and the gas-phase stream and catalyst to be regenerated pass from an outlet of the at least one riser and enter a gas-solid rapid separation zone; the separated gas-phase stream enters a separation section; a first portion of the separated catalyst returns to the pre-reaction zone, and a second portion is regenerated in a regenerator; wherein an inlet of the at least one riser extends into the pre-reaction zone, about 60% to about 90% of the height of the at least one riser passes through a heat exchange zone, and the outlet extends into the gas-solid rapid separation zone. | 2012-05-17 |
| 20120123180 | Method for Disposal of Drilling Waste, Contaminated Sediments and Residual Waste and a Disposal Facility for Same - This invention relates to a method of treatment and disposal of drilling waste, contaminated sediments and residual waste including the steps of providing drilling waste, contaminated sediments, residual waste or other disposable material, grinding or crushing the material, mixing the material with at least one binder, using material exhibiting a maximum particle size of less than 5 mm; transferring the mixture to a disposal device placed in a benthic zone and allowing the mixture to cure in the disposal device. A disposal facility formed by the method of this invention is described. | 2012-05-17 |
| 20120123181 | Charged Seed Cloud as a Method for Increasing Particle Collisions and for Scavenging Airborne Biological Agents and Other Contaminants - A system and method is provided for increasing interaction between seed particles in a seed cloud and target particles to be neutralized, detected or knocked down to the ground. This is achieved by applying a charge to the seed particles so that the seed cloud formed by release of the seed particles at altitude is highly charged, which in turn produces a strong electric field between the seed cloud and ground. The relatively strong electric field causes the seed particles to move downward (toward the ground) at a velocity sufficient to increase interaction (collisions) between the seed particles and the target particles. | 2012-05-17 |
| 20120123182 | DEVICES FOR THERMALLY INDUCED TRANSFORMATIONS CONTROLLED BY IRRADIATION OF FUNCTIONALIZED FULLERENES - An electromagnetic radiation activated device comprises a property changing material and at least one functionalized fullerene that upon irradiation of the functionalized fullerenes with electromagnetic radiation of one or more frequencies a thermally activated chemical or physical transformation occurs in the property changing material. The thermal activated transformation of the property changing material is triggered by the heating or combustion of the functionalized fullerenes upon their irradiation. The device can include a chemical agent that is embedded in the property changing material and is released when the material is heated by the functionalized fullerenes upon irradiation. | 2012-05-17 |
| 20120123183 | TELETHERAPY LOCATION AND DOSE DISTRIBUTION CONTROL SYSTEM AND METHOD - A method of adjusting an irradiation treatment plan, the plan constituted of: obtaining a plurality of reference scans of a target tissue over a breathing cycle; obtaining a pre-treatment scan of the target tissue; identifying the reference scan whose phase is consonant with the obtained pre-treatment scan; computing at least one motion vector field between the identified reference scan and another of the plurality of reference scans different from the identified reference scan; applying the at least one computed motion vector field to one of the obtained pre-treatment scan and the another of the plurality of reference scans so as to obtain at least one synthetic scan whose phase is consonant with the other of the obtained pre-treatment scan and the another of the plurality of reference scans; and adjusting one of an irradiation dose, irradiation angle and irradiation positioning responsive to the at least one synthetic scan. | 2012-05-17 |
| 20120123184 | SYSTEMS AND METHODS FOR OPTIMIZATION OF ON-LINE ADAPTIVE RADIATION THERAPY - Radiation treatment methods comprise: obtaining initial image data of a region of interest; initially optimizing one or more radiation delivery variables of a radiation treatment plan based on the initial image data; and dividing the plan into one or more fractional treatments. Each fractional treatment comprises: delivering an initial portion of a fraction based on the one or more initially optimized radiation delivery variables; obtaining fractional image data pertaining to the region of interest; fractionally optimizing the one or more radiation delivery variables based at least in part on the fractional image data; and delivering a subsequent portion of the fraction based on the one or more fractionally optimized radiation delivery variables. At least part of delivering the initial portion of the fraction overlaps temporally with at least one of: obtaining the fractional image data and fractionally optimizing the one or more radiation delivery variables. | 2012-05-17 |
| 20120123185 | RECTAL BALLOON APPARATUS WITH PRESSURE RELIEVING LUMEN AND SENSORS - A rectal balloon apparatus comprises a shaft having a fluid passageway extending therethrough. A rectal gas relieving lumen may be positioned with the shaft for removal of rectal gas. A motion detecting sensor and a radiation detecting sensor may be positioned with the balloon, the shaft, and/or the rectal gas release lumen. | 2012-05-17 |
| 20120123186 | THERAPEUTIC REGIMEN FOR TREATING CANCER - The invention provides a method for treating locally advanced resectable esophageal cancer in a human comprising (a) administering to the human a dose of a pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier and (ii) an adenoviral vector comprising a nucleic acid sequence encoding a human TNF-α and operably linked to a promoter, wherein the dose comprises about 4×10 | 2012-05-17 |
| 20120123187 | System and Method for Generating a Radiation Treatment Plan for Use in Effecting Radiation Therapy in a Human or Animal Body - The invention relates to a method for generating a radiation treatment plan and a radiation therapy treatment planning system for use in effecting radiation therapy of an anatomical portion of an animal body. The invention also relates to a radiation therapy delivery system. | 2012-05-17 |
| 20120123188 | SYSTEMS AND METHODS FOR TREATING CANCER USING BRACHYTHERAPY - Systems and methods are provided for treating cervical and/or uterine cancers in brachytherapy with an intracavitary brachytherapy applicator. The system comprises a tandem adapted for insertion into a cervix of a patient. An ovoid assembly comprises first and second inflatable ovoids and an ovoid support mechanism. The first and second inflatable ovoids are adapted for insertion within fornices of a patient. First and second retractors are adapted to be coupled to the ovoid assembly. The first retractor is adapted to be positioned to retract the bladder of a patient during treatment. The second retractor is adapted to be positioned to retract the rectum of a patient during treatment. The tandem and the first and second inflatable ovoids are adapted to be coupled to a radioactive source to deliver an implant radiation dose suitable for cancer treatment at a cancerous cervical treatment site in a patient. | 2012-05-17 |
| 20120123189 | ONCOLOGY THERAPIES EMPLOYING RADIOACTIVE SEEDS - An oncology therapy method comprises implanting a radioactive seed ( | 2012-05-17 |
| 20120123190 | ENHANCED FRICTION OF MICROPATTERNED SURFACES IMMERSED IN MAGNETORHEOLOGICAL FLUID - A method and system are provided for that allow for varying stiffness of a system by applying a low magnetic field to magnetorheological (MR) fluid in the system. The method and system include exposed patterns on facing surfaces of sliding structures. The facing patterns contain MR fluid. When a low to moderate magnetic field is applied to the MR fluid, the patterns are magnetically attracted to MR domains confined to the opposing surface, thus requiring additional force to slide the structures past each other. | 2012-05-17 |
| 20120123191 | THERAPEUTIC DEVICE - A therapeutic device comprising a first visual signaling element, a second visual signaling element positioned separately from the first visual signaling element, and a third visual signaling element positioned between the first and second visual signaling elements. A control apparatus controls the first, second and third signaling elements, and is arranged to alternately activate the first and second visual signaling elements for a first period of time, and to activate the third visual signaling element for a second period of time subsequent to the first period of time. | 2012-05-17 |
| 20120123192 | BED SYSTEM AND A PORTABLE COVER DEVICE FOR A BED - A bed system, comprising a bed ( | 2012-05-17 |
| 20120123193 | METHOD OF ASSESSING EMBRYO OUTCOME - Non-invasive methods of predicting embryo outcome by analyzing disclosed markers in embryo culture media. | 2012-05-17 |
| 20120123194 | PRESSURE LIMITING DEVICE FOR GASTRIC BAND ADJUSTMENT - A pressure sensing or monitoring device may be used with an implantable band system. In some versions, the device may be used with a syringe. The device may comprise a visual indicator for monitoring pressure. The device may govern operation of the syringe by setting a threshold pressure to limit the amount of pressure applied to an implantable band system by the syringe. | 2012-05-17 |
| 20120123195 | GASTRIC BAND WITH ASYMMETRICAL MEMBER - An apparatus comprises a strap and an inflatable bladder secured to the strap. The apparatus is sized and configured to wrap along a first plane to encompass an anatomical feature such as an esophagus or stomach. The bladder may have a cross-sectional profile that is asymmetric about the first plane, such as a tapered profile or a contoured profile. The wall thickness of the bladder may be substantially uniform or may vary about the perimeter of the bladder. The bladder may include an expansion section that allows the bladder to transition from having a substantially flat cross-sectional configuration in a non-inflated state to having a substantially tapered cross-sectional configuration an inflated state. The expansion section may include folds, pleats, gussets, or the like. The strap may have a cross-sectional profile that is asymmetric about the first plane. Such a strap may include annular ribs of varying sizes. | 2012-05-17 |
| 20120123196 | GASTRIC BAND DEVICES AND DRIVE SYSTEMS - Gastric banding devices, and drive systems designed to operate gastric banding devices, are disclosed. The gastric banding devices and drive systems intend to increase performance, durability, and simplicity over known gastric banding systems. Embodiments include transmission systems configured to output a variable force. Embodiments also include banding structures biased to apply a constrictive force to a patient's stomach. Supporting, or skeletal, structures are also disclosed. Various drive systems designed to improve power efficiency are also disclosed. | 2012-05-17 |
| 20120123197 | Implantable injection port with tissue in-growth promoter - A surgically implantable injection port has a tissue in-growth promoting surface associated with a fluid conduit that is coupled to the injection port. The injection port includes a housing, a fluid reservoir defined in part by the housing, a needle penetrable septum, a fluid conduit in communication with the reservoir, and a tissue in-growth promoting surface coupled to the fluid conduit. The tissue in-growth promoting surface may be provided by surgical mesh wrapped around the conduit or through which the conduit is threaded. The injection port and the fluid conduit may be used as part of a gastric band system or some other type of system. | 2012-05-17 |
| 20120123198 | PORT WITH CONDUIT WRAPAROUND FEATURE - An injection port includes a port body having a fluid reservoir and a connector in fluid communication with the reservoir. The injection port further includes a conduit protection feature that is configured to protect against kinking of the conduit, decoupling of the conduit from the connector, or penetration of the conduit by a needle. The protection feature may include an anchor for anchoring the conduit to tissue to reduce conduit movement. The protection feature may include a recess that is configured to receive part of the conduit. The protection feature may include a bend formed in the connector to reduce transverse stresses in the conduit. The protection feature may include a bell-shaped shroud encompassing the connector. A sleeve may further protect the conduit and/or the coupling between the connector and the conduit. | 2012-05-17 |
| 20120123199 | DEVICE FOR SEXUAL STIMULATION WITH SUPPLEMENTARY ELEMENT (VARIANTS) - The device for stimulating erogenous zones comprises a dildo and at least one additional stimulating element (ASE) attached to the dildo and including a body of rotation around an axis that is close to normal relative to a longitudinal axis of the dildo. A surface of the ASE projects above the dildo outer surface so that the ASE is able to roll over a surface of the erogenous zones. The ASE may include a ball or a cylinder. The surface of the ASE can be made relief. The device can be provided with a plurality of the ASE and at least a portion of the dildo can include a spiral frame, with the spiral fed through the plurality of the ASE. | 2012-05-17 |
